[1]Rossignol P, Massy ZA, Azizi M, et al.The double challenge of resistant hypertension and chronic kidney disease[J].The Lancet, 2015, 386(10003):1588-98
[2]Tanner RM, Calhoun DA, Bell EK, et al.Incident ESRD and treatment-resistant hypertension: the reasons for geographic and racial differences in stroke (REGARDS) study[J].Am J Kidney Dis, 2014, 63(5):781-8
[3]Hamrahian SM, Falkner B.Hypertension in Chronic Kidney Disease[J].Adv Exp Med Biol, 2017, 1(956):307-325
[4]de Beus E, Bots ML, van Zuilen AD, et al.Prevalence of Apparent Therapy-Resistant Hypertension and Its Effect on Outcome in Patients With Chronic Kidney Disease[J].Hypertension, 2015, 66(5):998-1005
[5] GBD 2013 Mortality and Causes of Death Collaborators.Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013[J].Lancet, 2015, 385(9963):117-171
[6]Bruck K, Stel VS, Gambaro G, et al.CKD Prevalence Varies across the European General Population[J].J Am Soc Nephrol, 2016, 27(7):2135-47
[7]Yano Y, Fujimoto S, Asahi K, et al.Prevalence of chronic kidney disease in China[J].Lancet, 2012, 380(9838):213-4
[8]Acharya T, Tringali S, Singh M, et al.Resistant hypertension and associated comorbidities in a veterans affairs population[J].J Clin Hypertens (Greenwich), 2014, 16(10):741-5
[9]Lotufo PA, Pereira AC, Vasconcellos PS, et al.Resistant hypertension: risk factors,subclinical atherosclerosis,and comorbidities among adults-the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)[J].Journal of clinical hypertension (Greenwich, Conn.), 2015, 17(1):74-80
[10]Judd E, Calhoun DA.Apparent and true resistant hypertension: definition,prevalence and outcomes[J].J Hum Hypertens, 2014, 28(8):463-8
[11]Achelrod D, Wenzel U, Frey S.Systematic review and meta-analysis of the prevalence of resistant hypertension in treated hypertensive populations[J].Am J Hypertens, 2015, 28(3):355-61
[12]Carey RM, Calhoun DA, Bakris GL, et al.Resistant Hypertension: Detection,Evaluation,and Management: A Scientific Statement From the American Heart Association[J].Hypertension, 2018, 72(5):e53-90
[13]中国高血压防治指南修订委员会, 中国高血压联盟, 中华医学会心血管病学分会中国医师协会高血压专业委员会, 等.中国高血压防治指南 年修订版[J].中国心血管杂志, 2019, 24(1):24-56
[14]Horowitz B, Miskulin D, Zager P.Epidemiology of hypertension in CKD[J].Adv Chronic Kidney D, 2015, 22(2):88-95
[15]Levey AS, Coresh J, Balk E, et al.National Kidney Foundation practice guidelines for chronic kidney disease: evaluation,classification,and stratification[J].Ann Intern Med, 2003, 139(2):137-47
[16]Zeng X, Zhang Y, Kwong JS, et al.The methodological quality assessment tools for preclinical and clinical studies,systematic review and meta-analysis,and clinical practice guideline: a systematic review[J].J Evid Based Med, 2015, 8(1):2-10
[17]周英凤, 顾莺, 胡雁, 等.循证卫生保健中心对关于不同类型研究的质量评价工具——患病率及分析性横断面研究的质量评价[J].护士进修杂志, 2018, 33(03):219-21
[18]顾莺, 张慧文, 周英凤, 等.循证卫生保健中心关于不同类型研究的质量评价工具——分析性研究的质量评价[J].护士进修杂志, 2018, 33(06):513-6
[19]Acelajado MC, Pisoni R, Dudenbostel T, et al.Refractory hypertension: definition,prevalence,and patient characteristics[J].Journal of clinical hypertension (Greenwich, Conn.), 2012, 14(1):7-12
[20]Gijón-Conde T, Graciani A, Banegas JR.Resistant hypertension: demography and clinical characteristics in 6,292 patients in a primary health care setting[J].Revista espanola de cardiologia (English ed.), 2014, 67(4):270-6
[21]Tanner RM, Shimbo D, Irvin MR, et al.Chronic kidney disease and incident apparent treatment-resistant hypertension among blacks: Data from the Jackson Heart Study[J].Journal of clinical hypertension (Greenwich, Conn.), 2017, 19(11):1117-24
[22]Zheng Y, Tang L, Chen X, et al.Resistant and undertreated hypertension in patients with chronic kidney disease: data from the PATRIOTIC survey[J].Clin Exp Hypertens, 2018, 40(8):784-91
[23]Persell SD.Prevalence of resistant hypertension in the United States,2003-2008[J].Hypertension, 2011, 57(6):1076-80
[24]Daugherty SL, Powers JD, Magid DJ, et al.Incidence and prognosis of resistant hypertension in hypertensive patients[J].Circulation, 2012, 125(13):1635-42
[25]Sim JJ, Bhandari SK, Shi J, et al.Characteristics of resistant hypertension in a large,ethnically diverse hypertension population of an integrated health system[J].Mayo Clin Proc, 2013, 88(10):1099-107
[26]Egan BM, Zhao Y, Li J, et al.Prevalence of optimal treatment regimens in patients with apparent treatment-resistant hypertension based on office blood pressure in a community-based practice network[J].Hypertension (Dallas, Tex.), 2013, 62(4):691-7
[27]Tanner RM, Calhoun DA, Bell EK, et al.Prevalence of apparent treatment-resistant hypertension among individuals with CKD[J].Clin J Am Soc Nephrol, 2013, 8(9):1583-90
[28]Thomas G, Xie D, Chen HY, et al.Prevalence and Prognostic Significance of Apparent Treatment Resistant Hypertension in Chronic Kidney Disease: Report From the Chronic Renal Insufficiency Cohort Study[J].Hypertension, 2016, 67(2):387-96
[29]Thomas G, Felts J, Brecklin CS, et al.Apparent Treatment-Resistant Hypertension Assessed by Office and Ambulatory Blood Pressure in Chronic Kidney Disease-A Report from the Chronic Renal Insufficiency Cohort Study[J].Kidney360, 2020, 1(8):810-818
[30]Verdalles U, Goicoechea M, Garcia DVS, et al.Prevalence and characteristics of patients with resistant hypertension and chronic kidney disease[J].Nefrologia, 2016, 36(5):523-9
[31]Kim S, Park JJ, Shin MS, et al.Apparent treatment-resistant hypertension among ambulatory hypertensive patients: a cross-sectional study from 13 general hospitals[J].Korean J Intern Med, 2021, 36(4):888-97
[32]Song SH, Kim YJ, Choi HS, et al.Persistent Resistant Hypertension Has Worse Renal Outcomes in Chronic Kidney Disease than that Resolved in Two Years: Results from the KNOW-CKD Study , [J].J Clin Med, 2021, 10(17):3998-3998
[33]Stengel B, Metzger M, Froissart M, et al.Epidemiology and prognostic significance of chronic kidney disease in the elderly--the Three-City prospective cohort study[J].Nephrol Dial Transplant, 2011, 26(10):3286-95
[34]Medcalf JF, Harris KP, Walls J.Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis[J].Kidney Int, 2001, 59(3):1128-33
[35]Tanaka S, Ninomiya T, Hiyamuta H, et al.Apparent Treatment-Resistant Hypertension and Cardiovascular Risk in Hemodialysis Patients: Ten-Year Outcomes of the Q-Cohort Study[J].Sci Rep, 2019, 9(1):1043-1043
[36]刘雪燕, 王光鹏, 张洁, 等.流行期间定点医院医护人员抑郁和焦虑患病率的分析[J].中国循证医学杂志, 2021, 21(09):1035-42
